Mary Latka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mary Latka has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
David Vlahov
Center for Urban Epidemiological Studies, New York Academy of Medicine, New York, NY, USA
2 shared publicationsCarol E. Farshy
Division of AIDS/STD/TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
1 shared publicationCarol Joanis
New York Academy of Medicine
1 shared publicationDonald C. Des Jarlais
Edmond de Rothschild Foundation Chemical Dependency Unit, Beth Israel Medical Center, New York, NY, USA
1 shared publicationErica Gollub
1 shared publicationEvie Andreopoulis
Center for Urban Epidemiological Studies, New York Academy of Medicine, New York, NY, USA
1 shared publication
Latest Publications
- 1 December 2005
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 29 (4) , 329-337
Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women
- 1 December 2005
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 29 (4) , 329-337
Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women
- Open Access
- 15 December 2003
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (s5) , S445-S450
Drug‐Using Women Need Comprehensive Sexual Risk Reduction Interventions
A training program was implemented for 56 health care professionals who work with injection drug users (IDUs) in Spain. The aims were to change health care professionals' concepts of drug treatment for IDUs and increase the knowledge required to implement effective drug treatment programs and train professionals who would in turn train other professionals, thus creating a network. Follow-up was carried out at 8 months. All of the professionals had little prior experience in designing and implementing risk reduction programs. At the end of the training program, all thought that they had increased their knowledge; had gained the skills required to design, implement, and evaluate harm reduction programs for IDUs; and felt qualified to train colleagues from other treatment centers. After 1 year, they had trained 676 health care professionals. The program is appropriate with regard to the aims sought and the target population for which it was designed. The effectiveness of a network-building strategy was also validated.
- 15 December 2003
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (s5) , S445-S450
Open AccessDrug‐Using Women Need Comprehensive Sexual Risk Reduction Interventions
A training program was implemented for 56 health care professionals who work with injection drug users (IDUs) in Spain. The aims were to change health care professionals' concepts of drug treatment for IDUs and increase the knowledge required to implement effective drug treatment programs and train professionals who would in turn train other professionals, thus creating a network. Follow-up was carried out at 8 months. All of the professionals had little prior experience in designing and implementing risk reduction programs. At the end of the training program, all thought that they had increased their knowledge; had gained the skills required to design, implement, and evaluate harm reduction programs for IDUs; and felt qualified to train colleagues from other treatment centers. After 1 year, they had trained 676 health care professionals. The program is appropriate with regard to the aims sought and the target population for which it was designed. The effectiveness of a network-building strategy was also validated.
- 1 December 2001
- Published by Springer Nature in Journal of Urban Health
- Vol. 78 (4) , 614-626
Acceptability of the Reality(R) Female Condom and a Latex Prototype
We report on the comparative acceptability of a prototype latex female condom and the polyurethane Reality female condom. We also identified factors associated with acceptability, measured via a composite index with domains related to ease of insertion, noise, and comfort during insertion and use. There were 135 couples in this randomized crossover trial. The average age was 30 years; more than 60% had education beyond high school; 40% were married; and participants were at low risk for sexually transmitted disease and pregnancy (due to the investigational status of the prototype). Participants were asked to use three of each of the study condoms during a 6-week period. Acceptability ratings on 12 items were summed into a composite index for each participant by condom type. The index midpoint (range) for females was 48 (12–84), and it was 32 (8–56) for males, with lower scores indicating higher acceptability (men completed only a subset of the acceptability questions). Both condoms were equally acceptable: Mean scores were 37 and 40 for the women's ranking of the prototype and Reality, respectively (P=.07) and 29 and 30 for men's rankings, respectively (P=.35). Multiple regression models to predict acceptability scores by gender were somewhat uninformative (most R 2 values were less than 0.10). Nevertheless, minority ethnicity (African American or Hispanic vs. white) was associated with higher acceptability by both genders for both condom types. Among women, for both condom types, less education (less than high school compared with high school or beyond) was associated with higher acceptability. Female condom acceptability may not be equally distributed across demographic groups, which is important for health educators to keep in mind when promoting the female condom.
- 1 December 2001
- Published by Springer Nature in Journal of Urban Health
- Vol. 78 (4) , 614-626
Acceptability of the Reality(R) Female Condom and a Latex Prototype
We report on the comparative acceptability of a prototype latex female condom and the polyurethane Reality female condom. We also identified factors associated with acceptability, measured via a composite index with domains related to ease of insertion, noise, and comfort during insertion and use. There were 135 couples in this randomized crossover trial. The average age was 30 years; more than 60% had education beyond high school; 40% were married; and participants were at low risk for sexually transmitted disease and pregnancy (due to the investigational status of the prototype). Participants were asked to use three of each of the study condoms during a 6-week period. Acceptability ratings on 12 items were summed into a composite index for each participant by condom type. The index midpoint (range) for females was 48 (12–84), and it was 32 (8–56) for males, with lower scores indicating higher acceptability (men completed only a subset of the acceptability questions). Both condoms were equally acceptable: Mean scores were 37 and 40 for the women's ranking of the prototype and Reality, respectively (P=.07) and 29 and 30 for men's rankings, respectively (P=.35). Multiple regression models to predict acceptability scores by gender were somewhat uninformative (most R 2 values were less than 0.10). Nevertheless, minority ethnicity (African American or Hispanic vs. white) was associated with higher acceptability by both genders for both condom types. Among women, for both condom types, less education (less than high school compared with high school or beyond) was associated with higher acceptability. Female condom acceptability may not be equally distributed across demographic groups, which is important for health educators to keep in mind when promoting the female condom.
- Open Access
- 1 December 2001
- Published by Springer Nature in Journal of Urban Health
- Vol. 78 (4) , 571-580
Female-initiated barrier methods for the prevention of STI/HIV: Where are we now? where should we go?
The female condom has been on the US marker for over 8 years and was hailed as a method that would allow women greater control in protecting themselves against unwanted pregnancy and sexually transmitted infections. However, since its launch, promotion of the female condom has met with challenges that vary from provider bias against the device, concerns about efficacy, and doubts about whether it will be used. While daunting, many of these challenges are not unique to the female condom. In fact, they parallel those of the tampon when it was first promoted in the US for menstrual hygiene in the early 1930s. Many providers were initially opposed to the tampon: early users found the tampon inadequate. Ten years after the introduction of the tampon and despite mass marketing, acceptability was mixed and use was modest (25% prevalence in a 26-city survey). Similar to female condom use observed in current-day prospective studies, users did not use the tampon exclusively or even predominantly. The story of the tampon demonstrates that a method does not have to be adopted by all users immediately to play an important role, and that even initially controversial methods can become widely accepted as mainstream. The early history of the tampon sheds perspective, and hope, on where we stand with the female condom. While much-needed work is under way to develop microbicides, we should take advantage of the fact that the female condom is already available and promote it to those in need now.
- 1 December 2001
- Published by Springer Nature in Journal of Urban Health
- Vol. 78 (4) , 571-580
Open AccessFemale-initiated barrier methods for the prevention of STI/HIV: Where are we now? where should we go?
The female condom has been on the US marker for over 8 years and was hailed as a method that would allow women greater control in protecting themselves against unwanted pregnancy and sexually transmitted infections. However, since its launch, promotion of the female condom has met with challenges that vary from provider bias against the device, concerns about efficacy, and doubts about whether it will be used. While daunting, many of these challenges are not unique to the female condom. In fact, they parallel those of the tampon when it was first promoted in the US for menstrual hygiene in the early 1930s. Many providers were initially opposed to the tampon: early users found the tampon inadequate. Ten years after the introduction of the tampon and despite mass marketing, acceptability was mixed and use was modest (25% prevalence in a 26-city survey). Similar to female condom use observed in current-day prospective studies, users did not use the tampon exclusively or even predominantly. The story of the tampon demonstrates that a method does not have to be adopted by all users immediately to play an important role, and that even initially controversial methods can become widely accepted as mainstream. The early history of the tampon sheds perspective, and hope, on where we stand with the female condom. While much-needed work is under way to develop microbicides, we should take advantage of the fact that the female condom is already available and promote it to those in need now.
- 17 August 2001
- Published by Elsevier in Journal of Substance Abuse
- Vol. 13 (1-2) , 73-88
Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users
- 17 August 2001
- Published by Elsevier in Journal of Substance Abuse
- Vol. 13 (1-2) , 73-88
Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users
- 1 September 2000
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 27 (8) , 431-437
Male-Condom and Female-Condom Use Among Women After Counseling in a Risk-Reduction Hierarchy for STD Prevention
A concern with hierarchy messages, which promote male condoms and female-controlled barrier methods along a prevention continuum, is that they may discourage condom use. To measure male-condom and female-condom use among women who received hierarchy counseling and compare this with women counseled about condoms only. Three observational cohorts that correspond to prevention message received were assembled, and consisted of female sexually transmitted disease clinic patients who were counseled about male condoms, female condoms, or a hierarchy message. The hierarchy message promoted male and female condoms, the diaphragm and cervical cap, spermicides, and withdrawal, in descending order of effectiveness against sexually transmitted diseases. After counseling, women were interviewed and returned for follow-up visits at 2 weeks, 4 months, and 6 months. The outcome was the mean proportion of male condom- or female condom-protected coital acts at each follow-up visit in the hierarchy cohort. The outcome was dichotomized as high (≥ 70% of coital acts protected) or low (< 70%), and generalized estimating equations were used to compare observed follow-up condom use with baseline within the hierarchy cohort and observed follow-up condom use between cohorts. It was assumed that condom use in persons not present at 6 months was equal to baseline levels, and condom use estimates were calculated for each full cohort that was initially enrolled. The mean proportion of condom-protected coital acts in the hierarchy cohort was significantly increased from baseline at each follow-up visit. There were no differences in observed condom use during follow up between the hierarchy cohort and either the male-condom or the female-condom cohort. However, when the full cohort initially enrolled was considered, 6-month condom use was significantly higher in the hierarchy cohort than in the male-condom cohort. Hierarchy counseling was associated with a significant increase in condom use. Our findings suggest that offering a choice of male and female condoms results in increased protection over counseling in male condoms alone.
- 1 September 2000
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 27 (8) , 431-437
Male-Condom and Female-Condom Use Among Women After Counseling in a Risk-Reduction Hierarchy for STD Prevention
A concern with hierarchy messages, which promote male condoms and female-controlled barrier methods along a prevention continuum, is that they may discourage condom use. To measure male-condom and female-condom use among women who received hierarchy counseling and compare this with women counseled about condoms only. Three observational cohorts that correspond to prevention message received were assembled, and consisted of female sexually transmitted disease clinic patients who were counseled about male condoms, female condoms, or a hierarchy message. The hierarchy message promoted male and female condoms, the diaphragm and cervical cap, spermicides, and withdrawal, in descending order of effectiveness against sexually transmitted diseases. After counseling, women were interviewed and returned for follow-up visits at 2 weeks, 4 months, and 6 months. The outcome was the mean proportion of male condom- or female condom-protected coital acts at each follow-up visit in the hierarchy cohort. The outcome was dichotomized as high (≥ 70% of coital acts protected) or low (< 70%), and generalized estimating equations were used to compare observed follow-up condom use with baseline within the hierarchy cohort and observed follow-up condom use between cohorts. It was assumed that condom use in persons not present at 6 months was equal to baseline levels, and condom use estimates were calculated for each full cohort that was initially enrolled. The mean proportion of condom-protected coital acts in the hierarchy cohort was significantly increased from baseline at each follow-up visit. There were no differences in observed condom use during follow up between the hierarchy cohort and either the male-condom or the female-condom cohort. However, when the full cohort initially enrolled was considered, 6-month condom use was significantly higher in the hierarchy cohort than in the male-condom cohort. Hierarchy counseling was associated with a significant increase in condom use. Our findings suggest that offering a choice of male and female condoms results in increased protection over counseling in male condoms alone.